Cargando…
Reversible Serum Carcinoembriogenic Antigen (CEA) Elevation Due to Orlistat Use: A Case Report
Autores principales: | dos Santos Fernandes, Gustavo, Katz, Atur, Calabrich, Aknar, Hoff, Paulo M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898556/ https://www.ncbi.nlm.nih.gov/pubmed/20613942 http://dx.doi.org/10.1590/S1807-59322010000600013 |
Ejemplares similares
-
Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
por: Katz, Artur, et al.
Publicado: (2009) -
Elevated Level of Serum Carcinoembryonic Antigen (CEA) and Search for a Malignancy: A Case Report
por: Asad-Ur-Rahman, FNU, et al.
Publicado: (2016) -
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023) -
Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007) -
Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)